Atricure Inc. buy UBS Group AG
Start price
30.10.24
/
50%
€29.29
Target price
30.10.25
€36.85
Performance (%)
3.79%
End price
31.10.25
€30.40
Summary
This prediction ended on 31.10.25 with a price of €30.40. With a performance of 3.79%, the BUY prediction by UBS_Group_AG for Atricure Inc. closed with a slight gain. UBS_Group_AG has a follow-up prediction for Atricure Inc. where he still thinks Atricure Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | -2.703% | -2.703% | -53.548% |
| iShares Core DAX® | -0.464% | -0.827% | 0.518% |
| iShares Nasdaq 100 | -1.413% | -3.024% | 27.534% |
| iShares Nikkei 225® | -1.246% | -7.626% | 45.082% |
| iShares S&P 500 | -1.147% | 0.585% | 21.655% |
Comments by UBS_Group_AG for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at UBS Group AG from $35.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten